Drugs not eligible for
Assumed Special Authority
The following medications continue to qualify for practitioner and specialty exemptions,
but are not eligible for Assumed Special Authority.
| abatacept & rituximab |
| adalimumab, etanercept & infliximab |
| ambrisentan |
| antibiotics |
| bosentan |
| botulinum
toxin |
| clostridium botulinum neurotoxin type A |
| epoprostenol |
| insulin detemir |
| insulin glargine |
| investigational drugs |
| leuprolide |
| ondansetron |
| ophthalmic quinolones |
| sildenafil |
| treprostinil |
|
